China National Medicines Corporation Ltd. (600511.SS) reported a profit for full year that Dropped, from the same period last year
The company's earnings totaled RMB1.996 billion, or RMB2.6462 per share. This compares with RMB2.000 billion, or RMB2.6509 per share, last year.
The company's revenue for the period rose 3.7% to RMB52.468 billion from RMB50.597 billion last year.
China National Medicines Corporation Ltd. earnings at a glance (GAAP) :
-Earnings: RMB1.996 Bln. vs. RMB2.000 Bln. last year.-EPS: RMB2.6462 vs. RMB2.6509 last year.-Revenue: RMB52.468 Bln vs. RMB50.597 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.